share_log

AEterna Zentaris Analyst Ratings

Benzinga ·  Jul 14, 2023 06:13
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
07/14/2023 865.52% HC Wainwright & Co. → $28 Reiterates Buy → Buy
05/12/2023 865.52% HC Wainwright & Co. → $28 Reiterates Buy → Buy
04/10/2023 865.52% HC Wainwright & Co. → $28 Reiterates → Buy
03/28/2023 865.52% HC Wainwright & Co. → $28 Reiterates → Buy
03/30/2022 -48.28% HC Wainwright & Co. $2 → $1.5 Maintains Buy
10/25/2021 -31.03% HC Wainwright & Co. → $2 Initiates Coverage On → Buy

What is the target price for AEterna Zentaris (AEZS)?

The latest price target for AEterna Zentaris (NASDAQ: AEZS) was reported by HC Wainwright & Co. on July 14, 2023. The analyst firm set a price target for $28.00 expecting AEZS to rise to within 12 months (a possible 865.52% upside). 4 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for AEterna Zentaris (AEZS)?

The latest analyst rating for AEterna Zentaris (NASDAQ: AEZS) was provided by HC Wainwright & Co., and AEterna Zentaris reiterated their buy rating.

When is the next analyst rating going to be posted or updated for AEterna Zentaris (AEZS)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of AEterna Zentaris, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for AEterna Zentaris was filed on July 14, 2023 so you should expect the next rating to be made available sometime around July 14, 2024.

Is the Analyst Rating AEterna Zentaris (AEZS) correct?

While ratings are subjective and will change, the latest AEterna Zentaris (AEZS) rating was a reiterated with a price target of $0.00 to $28.00. The current price AEterna Zentaris (AEZS) is trading at is $2.90, which is within the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment